Brief: Oasmia Expands Research And Development Ability With Planned Laboratory Upgrade
March 17 (Reuters) - Oasmia Pharmaceutical AB OASM.ST :
* OASMIA EXPANDS RESEARCH AND DEVELOPMENT ABILITY WITH
PLANNED
LABORATORY UPGRADE
* UPPSALA RESEARCH FACILITY UPGRADE WILL BROADEN RESEARCH
CAPABILITIES
Source text for Eikon: ID:nMFN9sGs2H
Further company coverage: OASM.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Vivesto AB
See all newsBrief: Vivesto Reports Positive Topline Results From Paccal Vet Study In Cats
Brief: Vivesto Says Topline Results For Paccal Vet 'Positive'
Brief: Vivesto Q2 Operating Loss At SEK 8.6 Mln
Brief: Vivesto: Positive Results From Exploratory Study With Cantrixil
Brief: Vivesto Appoints Björn Svanström As CFO